These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33134483)
21. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC. Hagedorn HJ; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Wisdom JP; Harris AH Implement Sci; 2016 May; 11():64. PubMed ID: 27164835 [TBL] [Abstract][Full Text] [Related]
22. HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions. Chander G; Monroe AK; Crane HM; Hutton HE; Saag MS; Cropsey K; Eron JJ; Quinlivan EB; Geng E; Mathews WC; Boswell S; Rodriquez B; Ellison M; Kitahata MM; Moore RD; McCaul ME Drug Alcohol Depend; 2016 Apr; 161():59-66. PubMed ID: 26857898 [TBL] [Abstract][Full Text] [Related]
23. Management of alcohol use disorder in patients with chronic liver disease. Mellinger JL; Fernandez AC; Winder GS Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314739 [TBL] [Abstract][Full Text] [Related]
24. A novel human laboratory model for screening medications for alcohol use disorder. Ho D; Towns B; Grodin EN; Ray LA Trials; 2020 Nov; 21(1):947. PubMed ID: 33225963 [TBL] [Abstract][Full Text] [Related]
25. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities. Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639 [TBL] [Abstract][Full Text] [Related]
26. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
27. Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department. Duvalyan E; Falade I; Fan W; Foe M; Mvemba A; Zussman JW; Geier C; LeSaint KT; Graglia S Acad Emerg Med; 2024 May; 31(5):456-462. PubMed ID: 38380769 [TBL] [Abstract][Full Text] [Related]
29. A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease. Twohig PA; Balasanova A; Cooper L; Le M; Khoury N; Manatsathit W; Olivera M; Peeraphatdit TB J Addict Med; 2024 Aug; ():. PubMed ID: 39150074 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Ohio Advanced Practice Registered Nurses' Rate of Prescribing Naltrexone for Patients With Alcohol Use Disorder Since Elimination of the X-Waiver. Wiggins M; Smith A; Helsabeck N J Am Psychiatr Nurses Assoc; 2024 Aug; ():10783903241271273. PubMed ID: 39155585 [TBL] [Abstract][Full Text] [Related]
31. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder. Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901 [TBL] [Abstract][Full Text] [Related]
32. Primary Care Provider HIV PrEP Knowledge, Attitudes, and Prescribing Habits: A Cross-Sectional Survey of Late Adopters in Rural and Suburban Practice. Sell J; Chen R; Huber C; Parascando J; Nunez J J Prim Care Community Health; 2023; 14():21501319221147254. PubMed ID: 36625276 [TBL] [Abstract][Full Text] [Related]
33. Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder. Belnap MA; McManus KR; Grodin EN; Ray LA Pharmaceut Med; 2024 Jul; 38(4):291-302. PubMed ID: 38967906 [TBL] [Abstract][Full Text] [Related]
34. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607 [TBL] [Abstract][Full Text] [Related]
35. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making. Bhardwaj A; Sousa JL; Huskamp HA; Busch AB; Kennedy-Hendricks A; Hodgkin D; Horgan C; Uscher-Pines L Ann Fam Med; 2023; 21(4):332-337. PubMed ID: 37487716 [TBL] [Abstract][Full Text] [Related]
36. The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder. Grunze H; Soyka M Expert Opin Pharmacother; 2022 Jul; 23(10):1181-1193. PubMed ID: 35640575 [TBL] [Abstract][Full Text] [Related]
37. Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care. Bernstein E; Guo N; Goto T; Rothberg MB J Gen Intern Med; 2021 Jul; 36(7):1989-1996. PubMed ID: 33515195 [TBL] [Abstract][Full Text] [Related]
38. Buprenorphine prescribing practice trends and attitudes among New York providers. Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694 [TBL] [Abstract][Full Text] [Related]
39. Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey. Bold KW; Deng Y; Dziura J; Porter E; Sigel KM; Yager JE; Ledgerwood DM; Bernstein SL; Edelman EJ Transl Behav Med; 2022 Jul; 12(6):726-733. PubMed ID: 35608982 [TBL] [Abstract][Full Text] [Related]